Writing the Future of Drug Discovery and Development - Dr. Tomasz Klaus

Pure Biologics was invited to the event: “Writing the Future of Drug Discovery and Development”, where Dr. Tomasz Klaus, Antibody Research Group Leader, presented the first results of partnering with Twist Bioscience Corporation.

The event took place on October 13, 2021 and gathered innovators working in drug development to share their research and discuss their thoughts on what the future holds for medicine. Pure Biologics, along with Pfizer and Novo Nordisk, was one of several partners invited to share their experiences and results.